search
Back to results

Dental Prophylaxis and Rheumatoid Arthritis (PREPARA II)

Primary Purpose

Rheumatoid Arthritis, Periodontitis, Gingivitis

Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Dental Prophylaxis
Sponsored by
University Hospital Heidelberg
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Rheumatoid Arthritis focused on measuring Disease Activity Score 28 (DAS28), Health Assessment Questionnaire (HAQ), Dental Scaling, Dental Polishing, Oral Health, Gingival Crevicular Fluid, Inflammatory Cytokine Profile, Biofilm, Oral Microbiome, Intestinal Microbiome

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Signed consent form
  • Diagnosis of an active Rheumatoid Arthritis (DAS28 > 3.2) by a rheumatologist
  • Gingiva Bleeding Index (GBI) > 10%, Plaque Control Record (PCR) > 30% (indication for Dental Prophylaxis following the Heidelberg Therapeutic Scheme)

Exclusion Criteria:

  • Generalized Severe Chronic Periodontitis
  • Periodontal treatment within the last 6 months
  • Dental Prophylaxis within the last 6 months
  • Dental Prophylaxis being contraindicated due to dental or other reasons
  • Antibiotic treatment within the last 3 months (excluding intake of antibiotic prophylaxis)

Sites / Locations

  • University Hospital HeidelbergRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Test

Control

Arm Description

Dental Prophylaxis at fist visit (T0), after 2 weeks (T1) and after 3 months (T2)

Wait & Control Study Design: Dental Prophylaxis after 3 months (T2) only

Outcomes

Primary Outcome Measures

Disease Activity Score 28 (DAS28)
The Disease Activity Score 28 (DAS28) combines single measures into an overall, continuous measure of Rheumatoid Arthritis disease activity. The DAS28 includes a 28 tender joint count, a 28 swollen joint count, acute phase reactant and a general health assessment on a visual analog scale.

Secondary Outcome Measures

Health Assessment Questionnaire (HAQ)
The Health Assessment Questionnaire (HAQ) is a comprehensive, validated, patient-oriented outcome assessment instrument. It includes the five dimensions disability, pain, medication effects, costs of care and mortality, which are then further subcategorized.
Microbiome and Inflammatory Cytokine Profile
The development of the bacterial microflora and inflammatory cytokine profile is being analyzed qualitatively and quantitatively by molecular genetic methods. Samples of supra- and subgingival plaque, gingival crevicular fluid and saliva are being collected at T0, T2 and T3, stool samples are being collected at T0 and T2.
Cumulative Steroid Dose
The cumulative steroid dose is being compared between Group 1 (Test) and Group 2 (Control).

Full Information

First Posted
March 15, 2017
Last Updated
May 3, 2017
Sponsor
University Hospital Heidelberg
search

1. Study Identification

Unique Protocol Identification Number
NCT03087240
Brief Title
Dental Prophylaxis and Rheumatoid Arthritis
Acronym
PREPARA II
Official Title
Influence of Dental Prophylaxis on Disease Activity of Rheumatoid Arthritis
Study Type
Interventional

2. Study Status

Record Verification Date
May 2017
Overall Recruitment Status
Unknown status
Study Start Date
February 28, 2017 (Actual)
Primary Completion Date
August 2019 (Anticipated)
Study Completion Date
February 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital Heidelberg

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluates the influence of dental prophylaxis on disease activity of Rheumatoid Arthritis. In addition to standard antirheumatic therapy, recently the question has been raised whether or not there is a supplementary beneficial effect due to professional teeth cleaning. So far just a few studies pursued this question, indicating that prophylaxis by dental professionals can alleviate the symptoms of Rheumatoid Arthritis. To further evaluate this question, in our study half of the participants will receive dental prophylaxis at their first visit, after 2 weeks and 3 months, while the other half will receive professional teeth cleaning after 3 months only.
Detailed Description
Periodontitis (PA) and Rheumatoid Arthritis (RA) both rely on an over-regulated immune response, leading to inflammation in joints and periodontium. It is known, that both diseases have a reciprocal influence and that therapy of one disease may have beneficial effects on the course of the other. This study evaluates the influence of dental prophylaxis on disease activity of Rheumatoid Arthritis, in addition to standard antirheumatic therapy. Patients are being recruited from the Department of Rheumatology at the Heidelberg University Hospital. Patients being diagnosed with an active Rheumatoid Arthritis (DAS28-Score > 3.2) will be included into the current study. The study follows a prospective, randomized, controlled study design with the participating dental and rheumatologic investigators being both blinded. The first visit (T0) includes the assessment of demographic and disease-related parameters, such as quality of life (HAQ - Health Assessment Questionnaire) and disease activity (DAS28 - Disease Activity Score 28) by a rheumatologist. Afterwards a dental investigator will determine the status of oral health with standard parameters (periodontal status (pocket depth, attachment level, Bleeding on Probing (BPI)) and dental status (DMFT - Decayed Missing Filled Teeth)). Subsequently patients are being randomized 1:1. The dental intervention is defined as a standardized dental prophylaxis according to the Heidelberg Therapeutic Scheme for Hygienization of the Oral Condition by means of professional teeth cleaning and motivational and demonstrational measures for implementing a sufficient oral hygiene. Group 1 (Test) contains patients being randomized for the dental intervention at first visit. Accordingly Group 2 (Control) contains patients not being randomized for the dental intervention. After 14 days (T1) patients in Group 1 undergo once again dental prophylaxis according the Heidelberg Therapeutic Scheme. The next follow-up is being executed after 3 months (T2) by rheumatologic and dental investigators again. The primary outcome consists of the evaluation of the disease activity of the Rheumatoid Arthritis measured by the DAS28-Score between first visit (T0) and after 3 months (T2). Patients of Group 2 receive dental prophylaxis after 3 months due to ethical reasons ("Wait & Control Study Design"). The final visit takes place after an additional 3 months (T3), in order to evaluate a possible long-term effect of the dental intervention. Furthermore the development of the bacterial microflora and inflammatory cytokine profile is being investigated. For this purpose, samples of supra- and subgingival plaque, gingival crevicular fluid and saliva at visits T0, T2 and T3 as well as stool samples at T0 and T2 are being collected. These will be analyzed qualitatively and quantitatively by molecular genetic methods.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rheumatoid Arthritis, Periodontitis, Gingivitis, Dental Prophylaxis
Keywords
Disease Activity Score 28 (DAS28), Health Assessment Questionnaire (HAQ), Dental Scaling, Dental Polishing, Oral Health, Gingival Crevicular Fluid, Inflammatory Cytokine Profile, Biofilm, Oral Microbiome, Intestinal Microbiome

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
70 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Test
Arm Type
Experimental
Arm Description
Dental Prophylaxis at fist visit (T0), after 2 weeks (T1) and after 3 months (T2)
Arm Title
Control
Arm Type
Other
Arm Description
Wait & Control Study Design: Dental Prophylaxis after 3 months (T2) only
Intervention Type
Procedure
Intervention Name(s)
Dental Prophylaxis
Other Intervention Name(s)
Professional Teeth Cleaning, Dental Scaling, Dental Polishing
Intervention Description
Prevention and treatment of periodontal diseases by cleaning of the teeth in the dental office using the procedures of dental scaling and dental polishing. The treatment includes plaque detection, removal of supra- and subgingival plaque and calculus, as well as motivation and demonstration for establishing a sufficient oral hygiene.
Primary Outcome Measure Information:
Title
Disease Activity Score 28 (DAS28)
Description
The Disease Activity Score 28 (DAS28) combines single measures into an overall, continuous measure of Rheumatoid Arthritis disease activity. The DAS28 includes a 28 tender joint count, a 28 swollen joint count, acute phase reactant and a general health assessment on a visual analog scale.
Time Frame
baseline (T0) and three months (T2)
Secondary Outcome Measure Information:
Title
Health Assessment Questionnaire (HAQ)
Description
The Health Assessment Questionnaire (HAQ) is a comprehensive, validated, patient-oriented outcome assessment instrument. It includes the five dimensions disability, pain, medication effects, costs of care and mortality, which are then further subcategorized.
Time Frame
baseline (T0) and three months (T2)
Title
Microbiome and Inflammatory Cytokine Profile
Description
The development of the bacterial microflora and inflammatory cytokine profile is being analyzed qualitatively and quantitatively by molecular genetic methods. Samples of supra- and subgingival plaque, gingival crevicular fluid and saliva are being collected at T0, T2 and T3, stool samples are being collected at T0 and T2.
Time Frame
baseline (T0), three months (T2) and six months (T3)
Title
Cumulative Steroid Dose
Description
The cumulative steroid dose is being compared between Group 1 (Test) and Group 2 (Control).
Time Frame
baseline (T0), three months (T2) and six months (T3)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Signed consent form Diagnosis of an active Rheumatoid Arthritis (DAS28 > 3.2) by a rheumatologist Gingiva Bleeding Index (GBI) > 10%, Plaque Control Record (PCR) > 30% (indication for Dental Prophylaxis following the Heidelberg Therapeutic Scheme) Exclusion Criteria: Generalized Severe Chronic Periodontitis Periodontal treatment within the last 6 months Dental Prophylaxis within the last 6 months Dental Prophylaxis being contraindicated due to dental or other reasons Antibiotic treatment within the last 3 months (excluding intake of antibiotic prophylaxis)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Diana Wolff, Prof. Dr. med. dent.
Phone
+49 (0)6221-56-6589
Email
diana.wolff@med.uni-heidelberg.de
First Name & Middle Initial & Last Name or Official Title & Degree
Kyrill Schoilew, Dr. med. dent.
Email
kyrill.schoilew@med.uni-heidelberg.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Diana Wolff, Prof. Dr. med. dent.
Organizational Affiliation
University Hospital Heidelberg
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Heidelberg
City
Heidelberg
ZIP/Postal Code
69120
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Diana Wolff, Prof. Dr. med. dent.
Phone
+49 (0)6221-56-6589
Email
diana.wolff@med.uni-heidelberg.de
First Name & Middle Initial & Last Name & Degree
Kyrill Schoilew, Dr. med. dent.
Email
kyrill.schoilew@med.uni-heidelberg.de
First Name & Middle Initial & Last Name & Degree
Diana Wolff, Prof. Dr. med. dent.
First Name & Middle Initial & Last Name & Degree
Björn Wolff, Dr. rer. nat.
First Name & Middle Initial & Last Name & Degree
Anna Felten, Dr. med. dent.
First Name & Middle Initial & Last Name & Degree
Niko Bender, Dr. med.
First Name & Middle Initial & Last Name & Degree
Kyrill Schoilew, Dr. med. dent.

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23370377
Citation
Janssen KM, Vissink A, de Smit MJ, Westra J, Brouwer E. Lessons to be learned from periodontitis. Curr Opin Rheumatol. 2013 Mar;25(2):241-7. doi: 10.1097/BOR.0b013e32835d833d.
Results Reference
background
PubMed Identifier
19335072
Citation
Ortiz P, Bissada NF, Palomo L, Han YW, Al-Zahrani MS, Panneerselvam A, Askari A. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol. 2009 Apr;80(4):535-40. doi: 10.1902/jop.2009.080447.
Results Reference
background

Learn more about this trial

Dental Prophylaxis and Rheumatoid Arthritis

We'll reach out to this number within 24 hrs